These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2203718)

  • 1. [Current aspects of hyposensitization].
    Albegger K
    HNO; 1990 Jul; 38(7):233-41. PubMed ID: 2203718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
    Malling HJ
    Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma.
    Zuberbier T; Bachert C; Bousquet PJ; Passalacqua G; Walter Canonica G; Merk H; Worm M; Wahn U; Bousquet J
    Allergy; 2010 Dec; 65(12):1525-30. PubMed ID: 21039596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
    Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
    Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978].
    Wüthrich B; Häfner G
    Schweiz Med Wochenschr; 1980 Feb; 110(8):281-90. PubMed ID: 7367848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities and limitations of hyposensitization treatment in airway allergies].
    Wahn U
    Ther Umsch; 1989 Sep; 46(9):625-32. PubMed ID: 2678573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyposensitization in bronchial asthma--still a current therapeutic procedure?].
    Baur X
    Med Klin (Munich); 1989 Sep; 84(9):439-44. PubMed ID: 2682160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practice of hyposensitization in allergic diseases].
    Wüthrich B
    Schweiz Rundsch Med Prax; 1993 May; 82(18):534-9. PubMed ID: 8497763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allergen-specific immunotherapy].
    Hansen TK; Svendsen UG
    Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro and contra of specific hyposensitization.
    Karl S; Ring J
    Eur J Dermatol; 1999 Jun; 9(4):325-31. PubMed ID: 10356415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of immunotherapy in treatment of IgE-induced allergic diseases].
    Müller UR
    Ther Umsch; 1994 Jan; 51(1):67-76. PubMed ID: 7511841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases.
    Moreno C; Cuesta-Herranz J; Fernández-Távora L; Alvarez-Cuesta E;
    Clin Exp Allergy; 2004 Apr; 34(4):527-31. PubMed ID: 15080803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Theoretical Basis of Hyposensitization. (author's transl.)].
    Kraft D
    Wien Klin Wochenschr Suppl; 1980; 117():12-4. PubMed ID: 6936975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.
    Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E
    Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.